FDA Says Anemia Drug Withdrawl Wasn’t For Safety

Manufacturer Hospira’s 2005 withdrawal of its leucovorin injection was not done for effectiveness or safety reasons, the FDA said, paving the way for new ANDAs on the generic anemia drug.
Generic Line